成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 162537-11-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 162537-11-3
Chemical Structure| 162537-11-3
Structure of 162537-11-3 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 162537-11-3 ]

Related Doc. of [ 162537-11-3 ]

Alternatived Products of [ 162537-11-3 ]
Product Citations

Product Details of [ 162537-11-3 ]

CAS No. :162537-11-3 MDL No. :MFCD07778455
Formula : C8H15NO4 Boiling Point : No data available
Linear Structure Formula :- InChI Key :NWPRXAIYBULIEI-RXMQYKEDSA-N
M.W : 189.21 Pubchem ID :11263950
Synonyms :
Chemical Name :(S)-2-((Methoxycarbonyl)amino)-3,3-dimethylbutanoic acid

Calculated chemistry of [ 162537-11-3 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.75
Num. rotatable bonds : 5
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 46.56
TPSA : 75.63 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.53 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.51
Log Po/w (XLOGP3) : 1.3
Log Po/w (WLOGP) : 0.84
Log Po/w (MLOGP) : 0.51
Log Po/w (SILICOS-IT) : -0.17
Consensus Log Po/w : 0.8

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.5
Solubility : 5.95 mg/ml ; 0.0315 mol/l
Class : Very soluble
Log S (Ali) : -2.49
Solubility : 0.614 mg/ml ; 0.00325 mol/l
Class : Soluble
Log S (SILICOS-IT) : -0.64
Solubility : 43.0 mg/ml ; 0.228 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.36

Safety of [ 162537-11-3 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 162537-11-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 162537-11-3 ]

[ 162537-11-3 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 162537-11-3 ]
  • 1-[4-(pyridin-2-yl)phenyl]-4(S)-hydroxy-5(S)-2,5-diamino-6-phenyl-2-azahexane trihydrochloride [ No CAS ]
  • [ 198904-31-3 ]
YieldReaction ConditionsOperation in experiment
84% With 4-methyl-morpholine; diisopropyl-carbodiimide; In dichloromethane; isopropyl alcohol; at -10 - 20℃;Inert atmosphere;Product distribution / selectivity; Example 1 : Preparation of atazanavir using 1 equivalent of compound (II), 3.5 equivalents of compound (III), 3.5 equivalents of DIC, and 6.6 equivalents of NMM97.5 g of 1 -[4-(piridyn-2-yl)phenyl-4(S)-hydroxy]-5-(S)-2,5-diamino-6-phenyl- 2-azahexane trihydrochloride (trihydrochloride of compound (II) with a 10%wt content of isopropanol, 185.97mmol) were suspended into 683 ml of dichloromethane under nitrogen atmosphere at -10 0C. 135 ml_ (1227.40 mmol) of /V-methylmorpholine were added maintaining the temperature at -10 0C.Separately, 100.8 ml_ (650.90 mmol) of N,N-diisopropylcarbodiimide were added to a suspension of 123.2 g (650.90 mmol) of N-(methoxycarbonyl)-L- tert-leucine (compound (III)) into 975 ml of dichloromethane.Then, the first suspension was quickly transferred over the second one. The resulting mixture was warmed up to room temperature and was maintained at such temperature until the reaction was completed (93% atazanavir by HPLC, monoimpurity content: 1.2%). The reaction mixture was filtered off and was washed with 800 ml_ of water. Then, the organic phase was concentrated up to half volume and 500 ml_ of tert-butylmethylether were added. The mixture was concentrated again up to half volume. This operation was repeated three times up to a dichloromethane content equal or less to 20%. The precipitated product was recovered by filtration. 125.4 g of atazanavir were obtained (Yield =96%). Purity by High Performance Liquid Chromatography (HPLC) = 98.2%, with 4% of N,N-diisopropylurea (DIU) and free of the other probable diastereomers. Molar yield =92%. Recrystallization in ethanol/water 45:55 yielded 105.34 g of atazanavir (149.5 mmol). Recrystallization yield: 84%. Purity HPLC = 99.4%, free of DIU, and free of the other probable diastereomers.The formula of the three probable diastereomers and the HPLC conditions to detect their presence are included below:d-ld-ll d-lHPLC conditions:Liquid chromatograph with UV detector equipped with automatic injector, and integration systemColumn: ZORBAX Eclipse XDB-C18 150x4.6 mm, 5mum.Mobile phase: A (0.05% formic acid in water) and B (ACN)Gradient elution:Detection: 254 nmFlow: 1 mL/minColumn temperature: 25 0CInjection: 2 muLTime injection and chromatogram: 20 minRelative retention time of the diastereomers (RRT):
  • 2
  • [ 857900-54-0 ]
  • [ 162537-11-3 ]
  • [ 198904-31-3 ]
  • 4
  • (2S,3S)-3-amino-4-phenyl-1-(1-(4-(pyridin-2-yl)benzyl)hydrazinyl)butan-2-ol hydrochloride [ No CAS ]
  • [ 162537-11-3 ]
  • [ 198904-31-3 ]
YieldReaction ConditionsOperation in experiment
To another flask N-methoxycarbonyl-(L)-tertiary leucine (V) (88.1 1 g, 0.47 mole), 1- (3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) (89.4 g, ' 0.47 mole), 1 -Hydroxy-benzotriazole (HOBT) (75.5 g, 0.49 mole) and dichloromethane (1000 mL) were charged and stirred at 25 - 30C for 4 - 5 hours. The aqueous layer of diamino compound (IV) obtained above in part A, and N, N-diisopropylethyl amine (DIPEA) (182.8 mL, 138 g) were added and stirred for 3 hours. The reaction mass was then washed with water, sodium bicarbonate solution and brine. The dichloromethane layer was concentrated to 100 - 150 ml_. Ethyl acetate (1000 ml.) was added and about half of the mixture of solvent was distilled out. n-Heptane (400 mL) was added and stirred for 1 hour at 65C. Cooled to 30C, solid was filtered, washed with mixture of ethyl acetate and n-heptane and dried to afford 101' g of atazanavir base (crude).
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Pharmaceutical Intermediates of
[ 162537-11-3 ]

Atazanavir Related Intermediates

Chemical Structure| 198904-85-7

[ 198904-85-7 ]

tert-Butyl 2-(4-(pyridin-2-yl)benzyl)hydrazinecarboxylate

Chemical Structure| 198904-84-6

[ 198904-84-6 ]

tert-Butyl 2-(4-(pyridin-2-yl)benzylidene)hydrazinecarboxylate

Chemical Structure| 72155-45-4

[ 72155-45-4 ]

tert-Butyl (S)-(1-oxo-3-phenylpropan-2-yl)carbamate

Chemical Structure| 87199-17-5

[ 87199-17-5 ]

4-Formylphenylboronic acid

Chemical Structure| 127406-56-8

[ 127406-56-8 ]

4-(Pyridin-2-yl)benzaldehyde

Related Functional Groups of
[ 162537-11-3 ]

Amino Acid Derivatives

Chemical Structure| 74761-42-5

[ 74761-42-5 ]

MOC-Val-OH

Similarity: 0.98

Chemical Structure| 171567-86-5

[ 171567-86-5 ]

(R)-2-((Methoxycarbonyl)amino)-3-methylbutanoic acid

Similarity: 0.98

Chemical Structure| 62965-35-9

[ 62965-35-9 ]

Boc-Tle-OH

Similarity: 0.89

Chemical Structure| 124655-17-0

[ 124655-17-0 ]

Boc-D-Tle-OH

Similarity: 0.89

Chemical Structure| 54895-12-4

[ 54895-12-4 ]

2-((tert-Butoxycarbonyl)amino)-3-methylbutanoic acid

Similarity: 0.87

; ;